Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Macular and Optic Disc Radial Peripapillary Vessel Density Using Optical Coherence Tomography Angiography in Gout Patients. | Diagnostics (Basel) | 2023 | 38132235 | PubTator, text mining | PubMed |
| Peripapillary and macular vascular densities in healthy, ocular hypertensive, and different stages of glaucomatous eyes. | Int J Ophthalmol | 2023 | 38111931 | PubTator, text mining | PubMed |
| Understanding Posterior Staphyloma in Pathologic Myopia: Current Overview, New Input, and Perspectives. | Clin Ophthalmol | 2023 | 38105912 | PubTator, text mining | PubMed |
| The Impact of COVID-19 Infection on Macular Capillary Perfusion. | Beyoglu Eye J | 2023 | 38089070 | PubTator, text mining | PubMed |
| [Are the assessments of individual out-of-pocket health services of the IGeL-Monitor in line with clinical guidelines?] | Gesundheitswesen | 2023 | 38081174 | PubTator, text mining | PubMed |
| The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential. | Front Cell Dev Biol | 2023 | 38078001 | PubTator, text mining | PubMed |
| Future direction for the deployment of deep learning artificial intelligence: Vision threatening disease detection in underserved communities during COVID-19. | Saudi J Ophthalmol | 2023 | 38074300 | PubTator, text mining | PubMed |
| Unveiling Distinct Proteomic Signatures in Complicated Crohn's Disease That Could Predict the Disease Course. | Int J Mol Sci | 2023 | 38069288 | PubTator, text mining | PubMed |
| From Vibrations to Visions: Raman Spectroscopy's Impact on Skin Cancer Diagnostics. | J Clin Med | 2023 | 38068480 | PubTator, text mining | PubMed |
| Semaphorin 6 Family-An Important Yet Overlooked Group of Signaling Proteins Involved in Cancerogenesis. | Cancers (Basel) | 2023 | 38067240 | PubTator, text mining | PubMed |
| Basosquamous Carcinoma: Comprehensive Clinical and Histopathological Aspects, Novel Imaging Tools, and Therapeutic Approaches. | Cells | 2023 | 38067165 | PubTator, text mining | PubMed |
| Diagnostic Challenges in ABCA4-Associated Retinal Degeneration: One Gene, Many Phenotypes. | Diagnostics (Basel) | 2023 | 38066771 | PubTator, text mining | PubMed |
| SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability. | Nat Commun | 2023 | 38062045 | PubTator, text mining | PubMed |
| Surgical management, use and efficacy of adjuvant dyes in idiopathic epiretinal membranes: a systemic review with network meta-analysis. | Int J Retina Vitreous | 2023 | 38057831 | PubTator, text mining | PubMed |
| Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3. | J Med Chem | 2023 | 38052451 | PubTator, text mining | PubMed |
| Transition to glycerol phenylbutyrate for the management of urea cycle disorders: clinical experiences. | Eur Rev Med Pharmacol Sci | 2023 | 38039045 | PubTator, text mining | PubMed |
| Membrane transporters in cell physiology, cancer metabolism and drug response. | Dis Model Mech | 2023 | 38037877 | PubTator, text mining | PubMed |
| Metastatic Seminoma Presenting in Kidney and Cervical Lymph Nodes after a 25-Year Interval: A Case Report and Literature Review. | Case Rep Oncol | 2023 | 38033414 | PubTator, text mining | PubMed |
| Long-Term Follow-Up of Brolucizumab in Macular Neovascularization. | Ophthalmic Res | 2023 | 38029730 | PubTator, text mining | PubMed |
| Compensatory Corneal Epithelial Changes After Femtolaser - Assisted Intracorneal Rings Implantation in Early and Moderate Cases of Keratoconus. | Clin Ophthalmol | 2023 | 38026597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=19